Standard InChI: InChI=1S/C21H20N4O7/c22-21-24-15-6-1-11(9-14(15)19(29)25-21)10-32-13-4-2-12(3-5-13)18(28)23-16(20(30)31)7-8-17(26)27/h1-6,9,16H,7-8,10H2,(H,23,28)(H,26,27)(H,30,31)(H3,22,24,25,29)
1.Patil SA, Shane B, Freisheim JH, Singh SK, Hynes JB.. (1989) Inhibition of mammalian folylpolyglutamate synthetase and human dihydrofolate reductase by 5,8-dideaza analogues of folic acid and aminopterin bearing a terminal L-ornithine., 32 (7):[PMID:2738891][10.1021/jm00127a026]
2.Hynes JB, Patil SA, Tomazic A, Kumar A, Pathak A, Tan XH, Li XQ, Ratnam M, Delcamp TJ, Freisheim JH.. (1988) Inhibition of murine thymidylate synthase and human dihydrofolate reductase by 5,8-dideaza analogues of folic acid and aminopterin., 31 (2):[PMID:3339615][10.1021/jm00397a031]
3.Hynes JB, Patil SA, Hagan RL, Cole A, Kohler W, Freisheim JH.. (1989) Comparison of the biological effects of selected 5,8-dideazafolate analogues with their 2-desamino counterparts., 32 (4):[PMID:2704031][10.1021/jm00124a019]
4.Dayam R, Aiello F, Deng J, Wu Y, Garofalo A, Chen X, Neamati N.. (2006) Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents., 49 (15):[PMID:16854058][10.1021/jm051296s]
5.Chen BK, Horváth C, Bertino JR.. (1979) Multivariate analysis and quantitative structure-activity relationships. Inhibition of dihydrofolate reductase and thymidylate synthetase by quinazolines., 22 (5):[PMID:110930][10.1021/jm00191a005]